Speakers 2021 ADC

Faraah Bekheet

Medical Student, Johns Hopkins University School of Medicine, Baltimore, MD
Cutaneous Nontuberculous Mycobacterial Infections: Risk Factors, Treatment, and Outcomes
Saturday April 10 | 3:35-3:45pm | Top Poster Session

Learning Objectives:
1. Develop awareness of the warning signs of cutaneous NTM infections
2. Understand the clinical decision-making process of treating cutaneous NTM infections
3. Describe adverse reactions to treatment and detection and management of recurrences

Johanna Choremis, MD, FRCSC, DABO

Assistant Professor of Ophthalmology, McGill University, Jewish General Hospital
Ocular Manifestations of Dermatologic Conditions
Friday April 9 | 4-4:10pm | Scientific Session 2

Learning Objectives:
1. Review of common dermatologic conditions with ocular manifestations
2. Tips for the dermatologist to recognize ocular associations without a slit lamp or through the patient’s symptoms

Larissa Geskin, MD

Professor of Dermatology, Columbia University
CTCL in COVID
Sunday April 11 | 9:35-10:15am

Julien Ghannoum, DMD

Oral and Maxillofacial Pathologist, CHUM and Maisonneuve-Rosemont Hospital, Montreal
Pearls of Oral Lichenoid Lesions
Friday April 9 | 4:10-4:20pm

Learning Objectives:
1. Describe the differential diagnosis of lichenoid lesions
2. Describe potential diagnostic pitfalls in oral lichenoid lesions

Joan Guitart, MD

Professor of Dermatology, Northwestern University
Subcutaneous Panniculitis-like Cutaneous Lymphoma
Sunday April 11 | 10:45 – 11:25am

Nadia Kashetsky 

MD Candidate, Faculty of Medicine, Memorial University of Newfoundland, St. John’s, Canada
Characteristics and Treatment Outcomes in Chromhidrosis: a Systematic Review
Saturday April 10 | 3:55-4:05pm | Top Poster Session

Learning Objectives:
1. To identify the clinical characteristics for the types of chromhidrosis: Apocrine Chromhidrosis (ACH), Eccrine Chromhidrosis (ECH), and Pseudochromhidrosis (PCH).
2. To identify the etiologies for each type of chromhidrosis.
3. To identify treatment and corresponding treatment outcomes for each type of chromhidrosis.

Mark Kirchhof, MD, PhD, FRCPC

Head of Dermatology Division, University of Ottawa, and the Ottawa Hospital
Acute and Chronic Cutaneous Manifestations of COVID-19
Friday April 9 | 1:25-1:55pm | Scientific Session 1

Learning Objectives:
1. Review the immunopathophysiology of COVID-19
2. Understand the variations in presentation of COVID-19
3. Explore the long term consequences of inflammation initiated by COVID-19

Jonathan Leventhal, MD

Director, Oncodermatology Clinic; Assistant Professor of Dermatology, Yale School of Medicine
Dermatologic toxicities from immune checkpoint inhibitors: Case-based challenges and lessons learned from the Yale Cancer Center
Friday April 9 | 2:55-3:25pm | Scientific Session 1

Learning Objectives:
1. Recognize common and uncommon dermatologic toxicities from immune checkpoint inhibitors by reviewing illustrative cases.
2. Evaluate and manage patients with recalcitrant dermatologic immune-related adverse events by emphasizing clinical pearls and therapeutic strategies.

Ashfaq A. Marghoob, MD

Attending Physician, Memorial Sloan Kettering Cancer Center
Difficult to diagnose melanoma
Friday April 9 | 2:25-2:55pm | Scientific Session 1

Learning Objectives:
1. Acknowledge the short comings of the ABCD rule for identifying melanoma.
2. Recognize the salient dermoscopy features to help identify melanomas lacking the ABCDs
3. Acknowledge the limitations of dermoscopy (unable to evaluate deep dermal lesions)

Catherine McCuaig, FRCPC, DABD

Clinical Professor of Dermatology in Pediatrics University of Montreal, Sainte-Justine University Hospital Center
10 Pearls in 10 Minutes in Pediatric Dermatology
Friday April 9 | 3:50-4:00pm | Scientific Session 2

Learning Objectives:
1. The participant will be at ease with using curettage with a small otic speculum for Mollusca Contagiosa
2. The participant will become knowledgeable of the latest treatments for vascular anomalies in children including infantile hemangioma
3. The participant will be cognisant of best practices in children with atopic dermatitis and psoriasis

Melissa Nantel-Battista, MD, FRCPC, FAAD

ACMS Member, CHUM University of Montreal
Surgical Pearls
Friday April 9 | 4:20-4:30pm | Scientific Session 2

Learning Objective:
Refining your surgical dermatologic practice with useful tips that will give you good and efficient results

Vincent Richer, MD, FRCPC, FAAD

Clinical Instructor and Director of Continuing Medical Education, Department of Dermatology and Skin Science, University of British Columbia
Sunscreens: Controversies & Compliance
Saturday April 10 | 11:50am-12:20pm | Scientific Session 3

Learning Objectives:
1.Enumerate strategies drawn from behavioural psychology to improve the effectiveness of sunscreen counselling, such as positive framing and colour priming
2. Discuss the evidence supporting the use of systemic photoprotection agents, such as Polypodium leucotomos
3. Contextualize sunscreen use within the COVID-19 era

Bertrand Richert, MD, PhD

Head and Chair, Brugmann, St Pierre and Queen Fabiola Children University Hospitals, Université Libre de Bruxelles, Belgium
10 Pearls in 10 Minutes on Nails
Friday April 9 | 4:30-4:40pm | Scientific Session 2

Learning Objectives:
1. Identify red flag signs in nail disorders
2. Define best approach in most common nail disorders

David Roberge, MD

Professor of Radiation Oncology, Université de Montréal
Radiation Therapy in Cutaneous Lymphoma
Sunday April 11 | 10:20 – 10:40am

Denis Sasseville, MD

Professor, Department of Experimental Medicine, McGill University Health Centre
Chronic Hand Dermatitis
Friday April 9 | 1:55-2:25pm | Scientific Session 1

Learning Objectives:
1. Be familiar with the classification of chronic hand dermatitis and its limitations.
2. Navigate the algorithm of the Canadian Hand Dermatitis Guidelines.
3. Recognize that cases of chronic hand dermatitis need to be individualized in terms of etiology, investigation and management.
4.Be aware of the potential role of newer biologic agents in the treatment of chronic hand dermatitis.

Neil Shear, MD, FRCPC, FACP, FCDA

Professor Emeritus, University of Toronto
Update on Cutaneous Drug Eruptions
Saturday April 10 | 11:20-11:50am

Learning Objectives:
1. Understand a structured and comprehensive approach to drug reaction consultations
2. Increase awareness about quantitative analyses in causality
3. Recognize controversies in emerging treatment strategies